Statin Side-Effects Mostly Not Caused by Drugs, Study Finds

Published: 06 February 2026. The English Chronicle Desk. The English Chronicle Online.

A landmark study confirms that most statin side-effects are not caused by the drugs, providing reassurance for patients. Researchers examined 19 randomised trials including 124,000 participants and found that, apart from muscle pain and diabetes, very few of the 66 listed side-effects have strong evidence of occurring due to statins. Changes in liver tests, minor liver abnormalities, urine changes, and tissue swelling were the only side-effects reliably linked to statins, and even these risks remained minimal.

Statins have been used globally for decades to reduce the risk of heart attacks, strokes, and other cardiovascular deaths, benefiting hundreds of millions of people. Despite these well-established benefits, long-standing safety concerns have deterred many from taking the medication, especially with official labels citing dozens of possible side-effects.

The researchers, publishing in The Lancet, emphasised that the majority of reported issues—including memory loss, depression, sleep disturbances, and tingling in hands or feet—showed no significant difference between those taking statins and those not taking them. Lead author Christina Reith, an associate professor at Oxford University, said the study provided “reliable evidence that commonly experienced events are not caused by statins.” She explained that memory or sleep problems occurred at similar rates in both statin users and non-users, underlining that these side-effects are not drug-related.

Reith added that while longer-term effects beyond the average follow-up of four and a half years cannot be entirely ruled out, the data provide “reassurance that, for most people, the benefits of statins far outweigh the risks.” Senior author Prof Sir Rory Collins noted that statin information leaflets require urgent revision to better reflect evidence and assist both patients and doctors in making informed choices about treatment.

The study further highlighted the need to counter misinformation about statins, which has contributed to underuse of life-saving medication. Prof Bryan Williams, chief scientific and medical officer at the British Heart Foundation, emphasised that statins remain crucial in preventing heart attacks and strokes, and that these findings should help reduce unnecessary deaths caused by cardiovascular disease.

Prof Victoria Tzortziou Brown, chair of the Royal College of GPs, reinforced that patients should feel reassured, though statins are not suitable for everyone. She stressed the importance of personalised medical advice, with GPs and patients discussing individual risks and benefits before initiating therapy.

This research is the most comprehensive evaluation to date, systematically reviewing decades of evidence and offering clarity on the safety profile of statins. The findings suggest regulatory authorities should update statin labels to remove misleading information about side-effects, helping to rebuild public confidence in the medication.

For decades, patients have been discouraged from using statins due to exaggerated safety warnings. This study confirms that the overwhelming majority of listed side-effects are coincidental rather than causal. By clarifying the real risks, the research aims to improve adherence to statin therapy, which remains essential for reducing cardiovascular complications worldwide.

Healthcare professionals have welcomed the study as a critical step in evidence-based prescribing. It encourages doctors to guide patients through informed decisions rather than rely solely on precautionary warnings. The findings also emphasise the importance of ongoing monitoring and communication between clinicians and patients to ensure optimal outcomes.

As cardiovascular disease remains a leading cause of death in the UK and globally, the confirmation that statin side-effects are mostly unfounded could have major implications for public health. Greater confidence in these medications may lead to broader uptake, preventing thousands of avoidable cardiac events each year.

While minor side-effects like liver enzyme changes, tissue swelling, and urinary alterations remain possible, these events are rare and generally manageable. Patients should continue to follow medical guidance and report any unusual symptoms, but the overarching message is one of reassurance and evidence-based clarity.

Experts agree that this research represents a turning point in the perception of statins. By separating myth from fact, the study promotes rational use of the drugs and could save lives by ensuring more people receive appropriate preventive therapy.

Ultimately, this landmark study reinforces that the real benefits of statins—reducing heart attacks, strokes, and premature deaths—far exceed the small and rare risks of side-effects. Accurate information and informed medical advice are vital to ensure these life-saving drugs reach those who need them most.

Check our latest news